Encompass Health Corporation
EHC
$108.95
$0.940.87%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.54B | 1.48B | 1.46B | 1.46B | 1.41B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.54B | 1.48B | 1.46B | 1.46B | 1.41B |
| Cost of Revenue | 865.60M | 849.40M | 830.80M | 824.50M | 819.10M |
| Gross Profit | 679.00M | 628.10M | 626.90M | 630.90M | 585.90M |
| SG&A Expenses | 88.20M | 71.00M | 74.10M | 67.20M | 75.00M |
| Depreciation & Amortization | 86.40M | 82.40M | 79.90M | 79.20M | 78.00M |
| Other Operating Expenses | 221.00M | 231.10M | 213.80M | 217.50M | 200.60M |
| Total Operating Expenses | 1.26B | 1.23B | 1.20B | 1.19B | 1.17B |
| Operating Income | 283.40M | 243.60M | 259.10M | 267.00M | 232.30M |
| Income Before Tax | 257.70M | 219.90M | 236.80M | 238.60M | 201.40M |
| Income Tax Expenses | 55.40M | 44.90M | 51.00M | 41.60M | 37.60M |
| Earnings from Continuing Operations | 202.30M | 175.00M | 185.80M | 197.00M | 163.80M |
| Earnings from Discontinued Operations | 800.00K | -400.00K | -900.00K | -500.00K | 400.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -57.00M | -48.10M | -42.80M | -45.00M | -43.30M |
| Net Income | 146.10M | 126.50M | 142.10M | 151.50M | 120.90M |
| EBIT | 283.40M | 243.60M | 259.10M | 267.00M | 232.30M |
| EBITDA | 369.80M | 326.00M | 339.00M | 346.20M | 310.30M |
| EPS Basic | 1.45 | 1.26 | 1.41 | 1.50 | 1.20 |
| Normalized Basic EPS | 1.04 | 0.89 | 1.05 | 1.04 | 0.83 |
| EPS Diluted | 1.43 | 1.24 | 1.39 | 1.48 | 1.18 |
| Normalized Diluted EPS | 1.02 | 0.87 | 1.03 | 1.02 | 0.81 |
| Average Basic Shares Outstanding | 100.20M | 100.50M | 100.60M | 100.50M | 100.00M |
| Average Diluted Shares Outstanding | 102.00M | 102.30M | 102.30M | 102.10M | 102.30M |
| Dividend Per Share | 0.19 | 0.19 | 0.17 | 0.17 | 0.17 |
| Payout Ratio | 13.00% | 13.44% | 12.03% | 11.88% | 14.06% |